Media coverage
1Media coverage
Title Plus Therapeutics Inc announces positive new interim data from its ongoing ReSPECT™ Phase 1 clinical trial Media name/outlet Impact Financial News Country United Kingdom Date 11/23/20 Persons Andrew Brenner
Press/Media: Press / Media
Media coverage
Title | Plus Therapeutics Inc announces positive new interim data from its ongoing ReSPECT™ Phase 1 clinical trial |
---|---|
Media name/outlet | Impact Financial News |
Country | United Kingdom |
Date | 11/23/20 |
Persons | Andrew Brenner |